PET scanning in clinical oncology

This publication has 20 references indexed in Scilit:

• Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET
  European Journal Of Cancer, 1997
• Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
  Radiology, 1997
• Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
  Seminars in Nuclear Medicine, 1996
• Cost-effectiveness of PET imaging in clinical oncology
  Nuclear Medicine and Biology, 1996
• Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
  Radiology, 1996
• Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer
  The Lancet, 1994
• Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findings
  Annals of Surgical Oncology, 1994
• The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease
  Annals of Surgery, 1992
• Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy
  The Laryngoscope, 1992
• Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic Tool
  Investigative Radiology, 1987